Copyright
©The Author(s) 2015.
World J Gastroenterol. Apr 7, 2015; 21(13): 3960-3969
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3960
Published online Apr 7, 2015. doi: 10.3748/wjg.v21.i13.3960
Table 2 Clinicopathological characteristics of hepatocellular carcinoma patients
| Characteristic | Cases |
| Age, yr | 59 ± 14 |
| Mean ± SD | |
| Gender | |
| Female | 94 |
| Male | 66 |
| Hepatitis | |
| HBV-positive | 68 |
| HCV-positive | 62 |
| Double-negative | 30 |
| Cirrhosis | |
| No | 77 |
| Yes | 80 |
| Unknown | 3 |
| Tumor size, cm | |
| ≤ 3 | 52 |
| > 3 | 108 |
| Nodule | |
| Solitary | 98 |
| Multiple | 62 |
| AFP level, ng/mL | |
| ≤ 10 | 45 |
| > 10 | 113 |
| Unknown | 2 |
| Stage | |
| I | 60 |
| II | 46 |
| III | 47 |
| IV | 7 |
| Invasion | |
| No | 85 |
| Yes | 75 |
| Recurrence | |
| No | 58 |
| Yes | 36 |
| Unknown | 66 |
| Survival | |
| No | 71 |
| Yes | 27 |
| Unknown | 62 |
-
Citation: Kuo CC, Shih YL, Su HY, Yan MD, Hsieh CB, Liu CY, Huang WT, Yu MH, Lin YW. Methylation of
IRAK3 is a novel prognostic marker in hepatocellular carcinoma. World J Gastroenterol 2015; 21(13): 3960-3969 - URL: https://www.wjgnet.com/1007-9327/full/v21/i13/3960.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i13.3960